Investigating how NOS3 and p38 MAP kinase interact and regulate each other
NOS3 and p38 MAP kinase - is the interaction between them a mechanism of p38 regulation?
This study is looking at how two important proteins in our bodies work together, which could help us find new ways to treat diseases like heart problems, diabetes, and cancer.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Kennesaw State University NIH-funded |
| Lab location | 1 site (Kennesaw, United States) |
| Project ID | NIH-10653595 on NIH RePORTER |
What this research studies
This research explores the interaction between Nitric Oxide Synthase 3 (NOS3) and p38 MAP kinase, two important proteins involved in cellular signaling. By examining how these proteins bind and influence each other's activity, the research aims to uncover mechanisms that could impact diseases such as atherosclerosis, diabetes, and cancer. The study will utilize advanced techniques like proximity ligation assays and biolayer interferometry to analyze these interactions in both laboratory settings and within living cells. This could lead to a better understanding of how to regulate these proteins for therapeutic purposes.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with atherosclerosis, diabetes, or certain types of cancer.
Not a fit: Patients with conditions unrelated to vascular signaling or those not affected by NOS3 or p38 MAP kinase may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for treating cardiovascular diseases and other conditions linked to NOS3 and p38 MAP kinase dysfunction.
How similar studies have performed: While the specific interaction between NOS3 and p38 MAP kinase is being explored in this research, similar studies have shown promise in understanding protein interactions in cellular signaling.
Where this research is happening
Kennesaw, United States
- Kennesaw State University — Kennesaw, United States (Active)
Researchers
- Principal investigator: Chrestensen, Carol Ann — Kennesaw State University
- Study coordinator: Chrestensen, Carol Ann
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.